Jia Miao, Ping Fu, Shuang Ren, Chao Hu, Ying Wang, Chengfeng Jiao, . . . Li Chen. (2022). Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual‐acting glucokinase activator. Wiley.
Chicago Style (17th ed.) CitationJia Miao, et al. Effect of Renal Impairment on the Pharmacokinetics and Safety of Dorzagliatin, a Novel Dual‐acting Glucokinase Activator. Wiley, 2022.
MLA (9th ed.) CitationJia Miao, et al. Effect of Renal Impairment on the Pharmacokinetics and Safety of Dorzagliatin, a Novel Dual‐acting Glucokinase Activator. Wiley, 2022.
Warning: These citations may not always be 100% accurate.